Crestline Management LP Invests $1.44 Million in Bath & Body Works, Inc. (NYSE:BBWI)

Crestline Management LP acquired a new stake in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 37,066 shares of the company's stock, valued at approximately $1,437,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Golden State Wealth Management LLC bought a new position in shares of Bath & Body Works during the fourth quarter worth $26,000. SRS Capital Advisors Inc. raised its holdings in shares of Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after purchasing an additional 329 shares during the period. UMB Bank n.a. lifted its holdings in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC raised its holdings in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after acquiring an additional 431 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works in the 3rd quarter valued at $39,000. 95.14% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on BBWI shares. Raymond James dropped their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating for the company in a research report on Thursday, April 17th. The Goldman Sachs Group dropped their target price on shares of Bath & Body Works from $49.00 to $42.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research report on Friday, February 28th. Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Barclays reduced their target price on shares of Bath & Body Works from $38.00 to $31.00 and set an "equal weight" rating for the company in a research note on Monday. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $41.44.

Bath & Body Works Trading Up 7.6%

NYSE BBWI traded up $2.36 during trading hours on Monday, reaching $33.41. The company had a trading volume of 4,858,806 shares, compared to its average volume of 4,814,652. Bath & Body Works, Inc. has a 1-year low of $24.96 and a 1-year high of $52.99. The stock has a 50-day moving average of $29.83 and a 200 day moving average of $33.84. The stock has a market capitalization of $7.12 billion, a P/E ratio of 8.15, a price-to-earnings-growth ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works announced that its board has approved a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.